Statistics for Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
Total visits
| views | |
|---|---|
| Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial | 6 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 1 |
| April 2025 | 1 |
File Visits
| views | |
|---|---|
| java.util.UUID:b5cdd595-ee0f-41c4-a9f0-c4765ca543bd | 14 |
| Sims2023Donanemab-PP.pdf | 1 |
| java.util.UUID:bc9cc3a8-f886-4499-af6e-392de712ba35 | 1 |
Top country views
| views | |
|---|---|
| United States | 5 |
| South Korea | 1 |
Top city views
| views | |
|---|---|
| Indianapolis | 3 |
| Franklin | 1 |
| Goyang-si | 1 |
| New Providence | 1 |